FNY Investment Advisers, LLC

Position in MRK — Merck & Co., Inc.

CIK 1742998 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$76,586

-$31,675 QoQ

Shares Held

596

-33.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#3,617

of 3,769 holders

Holding Since

Mar 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $3,050,095 across 6 Drug Manufacturers - General names. MRK ranks #3 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,393	$1,670,806
2	PFE	Pfizer Inc	50,150	$1,207,612
3	MRK	Merck & Co., Inc. This page	596	$76,586
4	NVO	Novo Nordisk A S	1,140	$54,651
5	AZN	Astrazeneca PLC	200	$37,924
6	ABBV	AbbVie Inc.	10	$2,516

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$76,586	596	-33.8%	Shares	Defined	2026-07-08
2026-03-31	$108,261	900	-91.2%	Shares	Sole	2026-04-15
2025-12-31	$1,073,652	10,200	+308.0%	Shares	Sole	2026-01-16
2025-03-31	$224,400	2,500	-88.9%	Shares	Sole	2025-04-17
2024-06-30	$2,785,500	22,500	+214.7%	Shares	Sole	2024-08-05
2024-03-31	$943,442	7,150	—	Shares	Sole	2024-05-03
No filing history on record for this holder in this stock.